INTRODUCTION
The synthesis and degradation of proteins, protein turnover, is a fundamental feature of living organisms, which characterizes their dynamic metabolic state, determines the pattern and range of biochemical and physiological function and enables metabolic control [l] . Whole-body protein turnover represents a summation of the rates of turnover in individual tissues, and we have been interested in its measurement and the way in which it changes in response to a range of nutritional, physiological and pathological stimuli [2, 3] . Inevitably, the measurement of protein turnover is indirect and different assumptions are associated with the use of one method or another [4] . In all methods, an amino acid labelled with a stable isotope is used to trace the fate of amino acids within the body, and assumptions are made about the representative nature of the metabolism of the amino acid and the specific label on that amino acid. It is to be expected that these assumptions might break down and no longer be tenable in certain extreme situations [5] . Therefore, as well as the pragmatic value of applying the methods to an understanding of different physiological states or disease conditions, there is interest in exploring the limits of the assumptions upon which the methods are based [4, 51. The 'precursor method' has been the approach most widely used, because of its relative ease of application for the investigator. In principle, a labelled amino acid is infused at a constant rate, and the flux of the amino acid in the body and its rate of oxidation are used to derive values for protein synthesis and degradation [4] . Except for a single example of its use in newborn infants [6] , the method has been invasive in practice. With the 'endproduct' method, isotope is given by mouth and flux rates are inferred from the pattern of excretion in end-products of metabolism, most usually urea and ammonia in urine. Because it is non-invasive, is acceptable for studies in children and has the potential for use in free-living individuals, we have continued to explore the applicability of the 'end product' method . In this method an amino acid labelled with I5N is taken, either orally or intravenously, either as a single dose or a continuous infusion. The amino acid used originally was glycine, and although there are situations in which the results obtained with glycine are unusual, it appears to be the amino acid which gives the most representative results for the flux of total N in the precursor pool [7, 101 . A recent comparison of the results in the literature, obtained using the precursor and end-product methods, showed remarkable agreement, considering the difference in the underlying assumptions [4] .
One practical disadvantage when using urea as the end-product is the need either to reach isotopic plateau enrichment in urinary urea or to ensure that the endogenous pool of urea is cleared of label. Attempts to reduce the time of study have involved priming of the urea pool to shorten the time to isotopic equilibrium. An appropriate prime for the urea pool inevitably leads to an overshoot in the enrichment of the ammonia pool. When we attempted to prime the ammonia pool we found that urinary ammonia enrichment reached a plateau at a much earlier point in time, after about 3 h, than had originally been appreciated [S] . The level of plateau enrichment in ammonia was much lower than had been seen before, and therefore the flux in the pool which was being traced appeared to be substantially higher than was achieved when the experiment was carried out over an 18 h period [S] . At the time, we had provisional evidence of a step function in the pattern of enrichment in urinary ammonia with time, as enrichment moved from an earlier to a later plateau [ll] . Such a pattern could not be produced by any combination of exponentials, as assumed by the conventional kinetics of protein turnover [l] . We considered that a move of this kind, from a lower to a higher level of plateau enrichment, might be indicative of a pool of protein which turned over with life-time kinetics, with label sequestered in the protein being returned to the precursor pool after a defined period [S] . Circadian rhythms in protein degradation might also account for the change, and have been described for proteins produced in the liver [12] , exocrine pancreas [13] or the remodelling of bone [14] . In a theoretical exploration of the mathematics of a model of this kind, we were able to demonstrate that if such a pool were to exist, there would be no effect upon the ultimate level of plateau enrichment, but the curve to plateau would show a succession of steps
In the present study we have sought direct experimental evidence for a 'step' in the enrichment in urinary ammonia, and hence evidence for a pool of proteins which turn over with life-time kinetics. If a step in the plateau for ammonia enrichment were due to a pool with life-time characteristics, then we would have predicted that the rise from the first plateau would relate directly to the time at which the infusion of label first commenced, and would be shifted to a later time when the infusion was started at a later time. This has been explored experimentally in the present work.
1111.

METHODS
Subjects
The study was approved by the joint ethical committee of Southampton and South West Hampshire Health Authority and the University of Southampton. All subjects agreed to participate after the nature of the study had been explained to them. Nine young adults were studied on a single occasion and one man and one women each underwent two study protocols, for a total of 13 study periods. There were three experimental protocols each of which lasted for 36 h. The subjects engaged in light activities during the daytime and retired to bed at their usual time, but were asked to waken every hour throughout the night. Protocol 1. Five men and one woman underwent Protocol 1. At some time before the study day, basal metabolic rate (BMR) was measured in duplicate under standardized conditions using a Datex, Deltatrac. The study started at 06.00 hours after an overnight fast. A sample of urine was passed at 06.00 h for the measurement of baseline enrichment. At 06.00 h and each hour for the next 36 h a dose of isotope was taken orally, feed consumed and urine passed. Energy intake for each subject was calculated as 1.55xBMR and the average protein intake was 1.4g of proteinday-l kg-'. The dietary intake was provided as Ensure (Abbott Laboratories, U.K.).
Protocol 2 . 7 3~0 men and three women underwent Protocol 2. A 3 day dietary recall was taken to determine habitual intake. An estimate of the habitual energy intake was derived with the use of Food Composition Tables. The subjects consumed their usual breakfast and the study started at 12.00 h, at which time a sample of urine was passed for the measurement of baseline enrichment. A number of subjects expressed a preference for sandwiches rather than the formula feed used in Protocol 1. At 12.00 h and each 1 h for the next 36 h a dose of isotope was taken orally, a sandwich eaten and urine passed. The estimated habitual energy intake was provided for the subjects for the duration of the study and the protein intake was set at 1.2g of protein day-' kg-', in the form of sandwiches of equal energy and protein content.
Protocol 3. Protocol 3 was carried out by one man who underwent Protocol 2, after an interval of 2 weeks, and one woman who underwent Protocol 2, after an interval of 4weeks. Urine was collected, isotope administered and sandwiches ingested as in Protocol 2, however, the study was started at 18.00 h, the subjects having consumed their habitual breakfast and lunch, and was continued for 36 h.
Isotope administration and urine collection
A solution of [lSN]glycine (99 atom-% excess; Cambridge Isotope Laboratories, Andover, MA, U.S.A.) was made up in sterile water and given orally in hourly doses at a rate of 1.33 pmol 15N h-' kg-l.
Urine was collected into 5 ml of 6 molA HC1 and stored frozen until analysis. Each urine was analysed f for ammonia-N and urea-N by the Berthelot reaction. Ammonia-N was isolated from urine by alkaline aeration, the ammonia-free urine was reacted with urease enzyme to hydrolyse the urea and the nitrogen was isolated as ammonia by alkaline aeration into sulphuric acid [15] . The nitrogen was liberated as gas by reaction with alkaline hypobromite in vucuo and the enrichment was measured by MS in a triple collector isotope ratio mass spectrometer (SIRA 10, VG Isogas, Middlewich, Cheshire, U.K.).
Calculations and statistical analysis
The level of enrichment in urinary ammonia and urea at plateau was used to calculate nitrogen flux according to the equation:
where Q is nitrogen flux in mg of N h-l kg-l, d is the rate of administration of [15N]glycine in mg of Nh-lkg-', and En, atom excess, is the plateau enrichment in the end-product. Plateau levels of enrichment were determined by visual inspection and confirmed by regressing the values for enrichment in either end-product against time. The slope was not significantly different from zero at either level of plateau for ammonia-N, nor for plateau enrichment in urea-N. A further comparison was carried out by comparing the slope of enrichment for the period before plateau had been achieved with the slope at plateau for similar durations. The slope before plateau was always significantly different from the slope at plateau. Rates of protein synthesis and protein degradation were derived from the equation:
where nitrogen flux Q is multiplied by 6.25 to convert to protein, I is a measure of protein intake, and protein degradation, Deg, is calculated by difference. Protein synthesis, Synth, is derived by difference, with E being an estimate of nitrogen lost from the body. Nitrogen losses were not measured directly, but were approximated from the excretion of urea-N and ammonia-N in urine.
Data were analysed on SPSS/pC+ (Statistical Package for Social Science), using paired t-tests and one-way analysis of variance. Statistical significance was accepted at the 5% level and post hoc tests employed the modified least-significant difference procedure.
RESULTS
The three protocols were completed by a total of 11 subjects who were aged from 20 to 42years (mean f SD 28 f 6). They were 1.63 i -0.08 m tall and weighed 65.9k10.0 kg, giving a body mass index of 22.7 f 3.9 kg/m2.
The pattern of enrichment in urinary ammonia, Fig. 1 , and urinary urea, Fig. 2 , with time was similar for each of the subjects. The panels in Fig. 1 show the change in enrichment in urinary ammonia with time when the studies were started at 06.00 hours, 12.00 hours and 18.00 hours, and in Fig. 3 the mean change in enrichment in urinary ammonia for Protocols 1 , 2 and 3 together can be seen. When the study was started at 06.00 hours the enrichment in urinary ammonia increased to a plateau by 4-7 h, and was maintained until 18 h (range 16-21 h) from the start of the study. At around 18 h enrichment increased once more and a further plateau was achieved at a higher level of enrichment at about 25 h (range 
22-28 h)
. By comparison, the rate of increase in enrichment in urinary urea-N was slower and plateau enrichment was poorly defined, but appeared to be achieved by the end of the study period, Figure 2 .
For the initial plateau in ammonia enrichment the coefficient of variability (CV) for the points at plateau enrichment within individuals was 8% on average (range 6.4-10.4%), while the CV for the points on the later plateau in ammonia was 9% on average (range 4-13%). For urea, the CV for the points at plateau for individuals was 4% on average (range 1-9%).
For Protocol 1, on a paired t-test the flux from ammonia, expressed as mmol N h-' kg-', at initial plateau (QA~), was significantly higher in each subject than the corresponding value at final plateau (QAz), Table 1 . A one-way analysis of variance between the two ammonia plateaux and the urea plateau showed that QAI was statistically significantly higher than Qm (Table 1) . This difference was reflected in the significantly higher rate of protein synthesis, SynthA1, when compared with the values at final plateau, Synthm, and in the rates of degradation, D e a l compared with D e w . The flux calculated from urea-N enrichment (Qu) was not significantly different to the value derived from the initial ammonia plateau, but significantly greater than that derived from the final plateau. The rate of synthesis and the rate of degradation followed a similar pattern to Qu, both being significantly greater than the values derived from the final plateau in ammonia enrichment. Figure 1 shows the pattern of enrichment in urinary arnmonia-N when the study was started at 06.00 hours in Protocol 1, at 12.00 hours in Protocol 2 and at 18.00 hours in Protocol 3. In Protocol 2, there was a rise in enrichment in ammonia-N to a plateau level of enrichment after about 4h. This plateau was maintained for about 10 h, before the enrichment increased to a new plateau value 18 h from the start of the study. The second plateau was held to the end of the study period. In Protocol 3, which started at 18.00 hours, there was a rise in enrichment in ammonia-N to a plateau level after about 4 h. This plateau was maintained for about 3 h, before the enrichment increased to a new plateau value 12 h from the start of the study. The second plateau was held to the end of the study period. In Fig. 3 the pattern of enrichment in urinary ammonia for the three protocols is compared directly. It is clear that, regardless of the time at which the study was started, enrichment in ammonia rose to a first plateau after a similar period of time and to a value which was similar for each protocol. Moreover, for each protocol the first plateau was maintained until the same time of the day, regardless of the time at which the study was begun. For each protocol the movement from the first plateau began around midnight. The achievement of the second plateau and the value for the second plateau were similar for each protocol, and on each occasion this was achieved between 02.00hours and 05.00 hours of the following day. There were no statistically significant differences in the values for nitrogen flux, protein synthesis or protein degradation amongst the three protocols, derived from either the enrichment of the first or second ammonia plateau or the urea plateau, Table 1 . For all the studies, QAI was significantly greater than Qu, and both were significantly greater than QM. Protein degradation was similarly different amongst the groups. Protein synthesis was statistically significantly different between SynthAl and both SynthAz and Synthu, but the difference between SynthAz and Synthu failed to achieve statistical significance (P = 0.08).
DISCUSSION
When glycine is given, either as a continuous infusion or in intermittent doses which approximate a continuous infusion, a plateau of enrichment is achieved at which inflow and outflow of isotope are equal. In such an isotopic steady state all outflows from the pool will have the same level of enrichment as the pool itself. This is the basis of the endproduct method of measuring protein turnover, with the enrichment of an end-product being taken to represent that of the precursor pool. The fact that the two end-products, ammonia and urea, have somewhat different enrichments has led to a modification of the theory, in which there are two precursor pools in parallel [7] , but this does not affect the general principle.
In this paper we are concerned mainly with urinary ammonia and the 'step' change in its enrichment curve. Urea shows little, if any, evidence of a step (Fig. 2) , presumably because of the slow turnover rate of the urea pool. For ammonia, the beginning of the step represents a falling-off in the 15N abundance from a smooth exponential increase to produce a temporary plateau (Ai): this plateau is Table 1 . Oral tracer doses of ['SN]glycine were given hourly for 36 h to normal adults who were consuming hourly feeds, and the rates of nitrogen flux (Q), protein synthesis (Synth) and protein degradation (Deg) were determined from the level of enrichment in an early (Al) or late (A2) plateau in urinary ammonia and a plateau in urinary urea (U). Significantly different from values derived from the early enrichment plateau, Al , *P < 0.05, " P <0.001. Significantly different from values derived from the late enrichment plateau, A2, tP <0.05, t t P <O.OOl. maintained for 9-12 h, and then there is a rather abrupt increase in abundance, which eventually reaches a new plateau (Az), or strictly, a pseudoplateau. One explanation for this behaviour could be a change in the pattern of amino acids, of varying enrichment, from which the end-product is derived. For example, with an infusion of [l5N]amide glutamine, which is the main precursor of urinary ammonia, acute acidosis produced an increase in the labelling of ammonia, suggesting an increase in the precursor pool of the proportion of highly labelled glutamine compared with other poorly labelled precursor amino acids [16] . With infusions of [15N]glycine, changes in the opposite direction might be expected, i.e. that acidosis would cause a decrease in ammonia labelling. However, there was no consistent increase in the rate of ammonia excretion that would suggest a significant degree of acidosis. The other possible explanation is change in the flux of unlabelled glycine through the precursor pool, the beginning of the step marking an increase, and the end of it a decrease, in flux. Measurement of isotopic abundance in [15N]glycine would be needed to distinguish between these possibilities. Changes in glycine flux cannot be related to food intake because the subjects were fed regularly every hour; nor can they be easily explained by differences in gastric emptying overnight, which would have to be substantial and sustained. An increase in glycine flux, initiating the step, could arise in several ways: an increase in de novo synthesis of glycine, liberation of glycine from glutathione or a change in protein degradation. There are no data which provide direct information on acute changes in de novo synthesis of glycine, although it is known to be reduced by a low-protein diet [17] . The hepatic concentration of glutathione varies on a diurnal basis [MI, but, from the calculations below, it seems unlikely that either de novo synthesis of glycine or breakdown of glutathione could occur to an extent that would explain the stepwise change in glycine flux. We are left, then, with protein degradation.
Intake Excretion
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Conventionally, it is assumed that the rise to plateau is by first-order kinetics [l] , resulting in a smooth curve, which, in a system as complicated as the whole body, represents a large number of superimposed exponentials. In a previous paper [ll] we showed that if we include in the model a mass of protein breaking down by life-time kinetics, a step would be produced in the curve of enrichment against time. This is a theoretical calculation which should apply to any amino acid used as a tracer. Modern studies by the precursor method have usually concentrated on measuring the plateau isotope abundance after some 4 h of infusion, with an initial priming dose. Under these conditions there is no possibility of observing a step.
It might be supposed that if the step results from the degradation of a pool of proteins with a life time of about 6 h, there would be a continuing series of steps at regular intervals, so that the final plateau is never reached. Our model [ l l ] shows that there is indeed such a series, but each successive step is smaller in height. Because the life time of the pool is so short, after the step has been repeated three times it can no longer be observed. At this time the isotopic abundance in the protein pool approaches that in the precursor pool; from the kinetic point of view it becomes part of the precursor pool, and the flux from it can no longer be measured.
When we come to the timing of the step, the present data do not fit the hypothesis of a life-time pool. Figures 1 and 3 show that when the experiment is started late in the day, Protocols 2 and 3, the first plateau is curtailed, and the move towards a second plateau begins at about midnight, lasts until 04.00 hours to 06.00 hours, and then settles to a new plateau which is maintained until evening. This is hardly compatible with a life-time pool and points to a true circadian increase and decrease of protein degradation in a rapidly turning over protein pool. Moreover, there is no reason to postulate non-random kinetics if the change in degradation occurs abruptly. A circadian step does not show up clearly on the second day, probably for the same reason as with a life-time pool, i.e. the rapidly turning over protein soon comes into equilibrium with the precursor pool [ll] . We have no way of determining what proportion of the body protein pool shows this circadian variation in flux, or whether the variation represents a large change in the flux through a small pool or a small change in a large pool. Only qualitative observations are possible.
Left with protein degradation as the most probable explanation of the step, we have to look for a source of protein in which degradation occurs with a circadian rhythm. Earlier we suggested that highly enriched proteins generated in the upper gastrointestinal tract that are relatively indigestible, e.g. cells, digestive enzymes, mucin, might ultimately be degraded by the action of the colonic microflora, with the return of label to the precursor pool [8, 111.
The timing would then be dependent on the transit time from the upper intestine to the colon. The present results with continuous feeding make this interpretation unlikely.
Examples of circadian rhythms in the secretion of proteins comprise many liver-produced proteins, including fibrinogen and coagulation factors [ 121, proteins secreted by the exocrine pancreas [13] , and the biliary output of lysosomal enzymes [19] . Unless, when newly synthesized, these proteins are protected by entering the secretory pathway, they are rapidly degraded . Thus, with constant synthesis, a change in the rate of secretion would entrain a change in the rate of degradation. Circadian rhythms have been observed in plasma amino acid patterns [24] , and the availability of specific amino acids has been suggested as a potential determinant of such rhythms . The hepatic concentration of glutathione varies on a diurnal basis
[18] and a circadian rhythm has also been described in the reduced glutathione content of bone marrow [28] . A further example is the remodelling of bone, which follows a daily cycle with evidence for a large increase in bone resorption during the night time. Structured remodelling would require degradation of collagen, which has a high content of glycine [14] . Although the absolute contribution made by circadian degradation of individual proteins might be small compared with the total mass of protein being turned over, based on a crude estimate, it could account for the magnitude of the step observed in the present studies. These examples raise the possibility that oscillations of the type described might be widespread and might involve the proteases responsible for protein degradation.
